111 related articles for article (PubMed ID: 9248330)
1. [Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].
Kawai Y; Fukushima T; Ookura K; Yoshio N; Yamauchi T; Nakayama T; Tohyama K; Wano Y; Tsutani H; Ueda T; Nakamura T
Rinsho Ketsueki; 1997 Jun; 38(6):532-8. PubMed ID: 9248330
[TBL] [Abstract][Full Text] [Related]
2. [Ex-vivo bleeding time as a control for platelet transfusion].
Söhngen D; Hattstein E; Heyll A; Kuntz BM; Meckenstock G; Schneider W
Beitr Infusionsther Transfusionsmed; 1994; 32():459-66. PubMed ID: 9480143
[TBL] [Abstract][Full Text] [Related]
3. [Determining clinical effectiveness of plasmapheresis thrombocyte preparations].
Kirsten K
Beitr Infusionsther; 1992; 30():149-51. PubMed ID: 1284693
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
5. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing 20-hour increments after platelet transfusion.
Bishop JF; Matthews JP; McGrath K; Yuen K; Wolf MM; Szer J
Transfusion; 1991 Jun; 31(5):392-6. PubMed ID: 2048176
[TBL] [Abstract][Full Text] [Related]
7. Calculated platelet dose: Is it useful in clinical practice?
Askari S; Weik PR; Crosson J
J Clin Apher; 2002; 17(2):103-5. PubMed ID: 12210715
[TBL] [Abstract][Full Text] [Related]
8. In vivo efficacy of shipped HLA-matched platelets.
Haddad SA; Lichtiger B; Klein HG
Transfusion; 2006 Aug; 46(8):1306-10. PubMed ID: 16934064
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
[TBL] [Abstract][Full Text] [Related]
10. [Marked hematologic improvement despite deterioration of marrow cell dysplasia in a refractory anemia patient treated with vitamin D3].
Wakimoto N; Kimura F; Sato K; Kuwada N; Matsumura T; Yamashita T; Nakamura Y; Yoshida M; Nakamura Y; Motoyoshi K
Rinsho Ketsueki; 1999 May; 40(5):408-13. PubMed ID: 10390890
[TBL] [Abstract][Full Text] [Related]
11. [Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].
Murase K; Matsunaga T; Takimoto R; Takahira N; Fujimi A; Takeuchi N; Terui T; Niitsu Y
Rinsho Ketsueki; 2004 May; 45(5):383-6. PubMed ID: 15199747
[TBL] [Abstract][Full Text] [Related]
12. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
13. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions.
Brooks EG; MacPherson BR; Fung MK
Transfusion; 2008 Oct; 48(10):2159-66. PubMed ID: 18631168
[TBL] [Abstract][Full Text] [Related]
14. [Post-transfusion rise in thrombocytes: observations in a hematologic-oncologic patient sample].
Böck M; Muggenthaler KH; Schmidt U; Heim MU; Mempel W
Infusionsther Transfusionsmed; 1995 Dec; 22(6):350-4. PubMed ID: 8589595
[TBL] [Abstract][Full Text] [Related]
15. [Effective combination therapy by recombinant erythropoietin and cepharanthin in a girl with refractory anemia].
Kitajima H; Anzai K; Kubo M; Hoshi Y; Akatsuka J
Rinsho Ketsueki; 1994 Jul; 35(7):694-8. PubMed ID: 8065023
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
17. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
Tanai C; Iki S; Nakahara F; Iijima K; Usuki K; Kuwana M; Urabe A
Rinsho Ketsueki; 2004 Nov; 45(11):1181-6. PubMed ID: 15609684
[TBL] [Abstract][Full Text] [Related]
18. Patient and product factors affecting platelet transfusion results.
Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
[TBL] [Abstract][Full Text] [Related]
19. [Thrombocyte transfusion: clinical aspects, follow-up and complications].
Söhngen D; Schneider W
Klin Wochenschr; 1991 Jun; 69(9):379-86. PubMed ID: 1921239
[TBL] [Abstract][Full Text] [Related]
20. [Test of activated plasma clotting time to assess efficacy of platelet transfusion].
Li JJ; Chen BA; Huang CY; Li CP; Shi GY; Xiao JY; Ding JH; Gao C; Sun YY; Wan J; Cheng J; Zhao G; Song HH; Zhong YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):108-11. PubMed ID: 17490533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
